GNE-0877
- Generic Name
- GNE-0877
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL201 in Healthy Volunteers
- First Posted Date
- 2020-09-16
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- Denali Therapeutics Inc.
- Target Recruit Count
- 122
- Registration Number
- NCT04551534
- Locations
- 🇺🇸
Clinical Site(s), Dallas, Texas, United States
Study to Evaluate DNL201 in Subjects With Parkinson's Disease
- First Posted Date
- 2018-10-18
- Last Posted Date
- 2020-01-13
- Lead Sponsor
- Denali Therapeutics Inc.
- Target Recruit Count
- 29
- Registration Number
- NCT03710707
- Locations
- 🇺🇸
Clinical Site(s), Spokane, Washington, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath